You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
扭虧為盈 智雲健康2023年第四季度實現首個單季度盈利
格隆匯 01-29 19:00
智雲健康今日發佈盈利預喜公吿,初步評估,2023年第四季度成為公司首個盈利季度,實現單季度扭虧為盈。據悉,2023年第四季度的單季度盈利保守預計超過千萬。公吿稱,四季度對公司2023全年經調整淨虧損收窄將有巨大貢獻,預計全年經調整淨虧損6500萬-7800萬,同比收窄76.6%-80.5%。經調整淨虧損預期同比大幅下降,智雲健康表示,基於覆蓋全國近2700家醫院、超過20萬家藥店(佔全國藥店數量的1/3)的規模化SaaS網絡與數字化能力優勢,公司有能力建立在醫院和藥店具有高滲透率的P2M(Patient to Manufacturer,從患者到工業)模式,實現從患者到工業的高效連接,推動醫院解決方案、院外解決方案兩個主要業務板塊的強勢增長;同時,公司的經營槓桿受益於獨特的商業模式、良好的行業聲譽、強大的SaaS網絡以及客户的高粘性和高復購不斷提升,且有效的成本控制進一步縮減了行政開支,整體經營業績持續向好。資料顯示,智雲健康科技集團(9955.HK)成立於2014年,是中國領先的數字化慢病管理解決方案提供商。公司自主研發的醫院SaaS系統、藥店SaaS系統以及先進的互聯網醫院平台為用户提供院內解決方案、藥店解決方案和個人慢病管理解決方案,覆蓋了院內院外數字化慢病管理的全生命週期,目前已為全國近2700家醫院、逾20萬家藥房提供服務。公司打通產業鏈上下游,佈局原研藥、醫學檢驗和病理診斷等業務板塊,持續深化“數字技術+傳統醫療”生態建設的協同機制。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account